Surg Endosc21 Dec 2023
Patients with BCLC stage 0/A hepatocellular carcinoma (HCC) and clinically significant portal hypertension (CSPH) who underwent laparoscopic hepatectomy had worse overall and recurrence-free survival rates compared to those without CSPH. However, CSPH patients treated laparoscopically had better short- and long-term prognoses than those treated with…
Surg Endosc21 Dec 2023
After the learning curve, robotic pancreatoduodenectomy (RPD) demonstrated improved oncologic outcomes in patients with pancreatic duct adenocarcinoma (PDAC) compared to open pancreatoduodenectomy (OPD). A retrospective analysis of 548 patients revealed that RPD had longer overall survival (33.2 months vs. 25.7 months) and disease-free survival (18.5…
J Am Coll Surg20 Dec 2023
A retrospective study of 199 patients with localized small- and large-cell pancreatic neuroendocrine carcinoma (pannec) found that resection was associated with improved overall survival, while adjuvant chemotherapy did not significantly impact survival. The study also revealed an increasing trend in the rates of resection and…
J Am Coll Surg20 Dec 2023
Researchers evaluated the correlation between successful patient-derived xenograft (PDX) engraftment and survival in pancreaticobiliary cancer. They implanted 384 PDX models and found a 41% engraftment rate. Successful engraftment was strongly associated with both recurrence-free survival and overall survival outcomes. Furthermore, successful PDX tumor generation occurred…
BMC Surg19 Dec 2023
The systematic review and Bayesian network meta-analysis compared outcomes of high-volume, medium-volume, and low-volume hospitals performing liver resections. The analysis included 20 studies and 248,707 patients. The results indicated a significant association between hospital volume and postoperative mortality, favoring high-volume hospitals. Patients from high-volume hospitals…
HPB & Spleen19 Dec 2023
The main result of this study is the identification of three main categories that influence the implementation of early mobilisation in pancreatic surgery: attitude towards early postoperative mobilisation, subjective norm, and perceived behavioural control. These factors, which include perceived advantages or disadvantages, impact from healthcare…
Ann Surg18 Dec 2023
Surgeons' ability to accurately predict surgical margins following resection of colorectal liver metastases (CRLM) was evaluated in this study. The analysis included 190 preoperative and 190 postoperative assessments from 95 cases, comparing surgeon assessments to histopathologic assessment. Results showed that surgeons are inaccurate at predicting…
Br J Surg18 Dec 2023
Approximately 36% of patients who undergo non-pancreatic upper gastrointestinal surgeries develop pancreatic exocrine insufficiency (PEI), which can have detrimental effects on their health. The incidence of PEI was found to be 23% after bariatric metabolic surgery and 50.4% after oesophagogastric resection, with even higher rates…
Ann Surg Oncol18 Dec 2023
Robotic Pancreatoduodenectomy in a patient with Type III Portal Annular Pancreas (PAP) was successfully performed using the hanging maneuver and indocyanine green (ICG) fluorescence imaging. The technique involved transecting the pancreas into the neck of the anteportal portion and stapling the retroportal portion after dissection…
Surg Endosc18 Dec 2023
Three randomized controlled trials have reported improved functional recovery after laparoscopic pancreatoduodenectomy (LPD) compared to open pancreatoduodenectomy (OPD). This monocentric retrospective cross-sectional study found that patients who underwent LPD had significantly higher quality of life scores, better pancreas specific health status, improved physical functioning, and…